Nancy Wysenski - Net Worth and Insider Trading
Nancy Wysenski Net Worth
The estimated net worth of Nancy Wysenski is at least $13 Million dollars as of 2024-04-28. Nancy Wysenski is the EVP, Chief Commercial Officer of Vertex Pharmaceuticals Inc and owns about 32,232 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $13 Million. Nancy Wysenski is also the Director of Alkermes PLC and owns about 27,071 shares of Alkermes PLC (ALKS) stock worth over $668,112. Details can be seen in Nancy Wysenski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nancy Wysenski has not made any transactions after 2023-05-09 and currently still holds the listed stock(s).
Transaction Summary of Nancy Wysenski
Nancy Wysenski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy Wysenski owns 7 companies in total, including Provention Bio Inc (PRVB) , Alkermes PLC (ALKS) , and Dova Pharmaceuticals Inc (DOVA) among others .
Click here to see the complete history of Nancy Wysenski’s form 4 insider trades.
Insider Ownership Summary of Nancy Wysenski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRVB | Provention Bio Inc | 2020-05-19 | director |
| ALKS | Alkermes PLC | 2023-05-09 | director |
| DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director |
| TTPH | Tetraphase Pharmaceuticals Inc | 2019-06-10 | director |
| INO | Inovio Pharmaceuticals Inc | 2016-05-08 | director |
| VRTX | Vertex Pharmaceuticals Inc | 2012-05-14 | EVP & Chief Commercial Officer |
| CYTK | Cytokinetics Inc | 2020-11-20 | director |
Nancy Wysenski Latest Holdings Summary
Nancy Wysenski currently owns a total of 2 stocks. Among these stocks, Nancy Wysenski owns 32,232 shares of Vertex Pharmaceuticals Inc (VRTX) as of May 14, 2012, with a value of $13 Million and a weighting of 95.04%. Nancy Wysenski also owns 27,071 shares of Alkermes PLC (ALKS) as of May 9, 2023, with a value of $668,112 and a weighting of 4.96%.
Latest Holdings of Nancy Wysenski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2012-05-14 | 32,232 | 397.48 | 12,811,575 |
| ALKS | Alkermes PLC | 2023-05-09 | 27,071 | 24.68 | 668,112 |
Holding Weightings of Nancy Wysenski
Nancy Wysenski Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy Wysenski has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 180,000 shares on May 14, 2012, which brought Nancy Wysenski around $12 Million.
According to the SEC Form 4 filings, Nancy Wysenski has made a total of 2 transactions in Alkermes PLC (ALKS) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Alkermes PLC is the sale of 41,250 shares on May 9, 2023, which brought Nancy Wysenski around $1 Million.
Insider Trading History of Nancy Wysenski
- 1
Nancy Wysenski Trading Performance
GuruFocus tracks the stock performance after each of Nancy Wysenski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Wysenski is -24.37%. GuruFocus also compares Nancy Wysenski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Wysenski within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nancy Wysenski's insider trading performs compared to the benchmark.
Performance of Nancy Wysenski
Average Return
-25.4%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.86 | -24.37 | -24.18 | -25.4 | -5.82 | 0.21 |
| Relative Return to S&P 500(%) | -2.55 | -21.58 | -30.9 | -34.47 | -22.71 | -10.42 |
Nancy Wysenski Ownership Network
Ownership Network List of Nancy Wysenski
Ownership Network Relation of Nancy Wysenski
Nancy Wysenski Owned Company Details
What does Provention Bio Inc do?
Who are the key executives at Provention Bio Inc?
Nancy Wysenski is the director of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & Chief Scientific Officer Francisco Leon , and director & 10 percent owner & President and CEO Ashleigh Palmer .
Provention Bio Inc (PRVB) Insider Trades Summary
Over the past 18 months, Nancy Wysenski made no insider transaction in Provention Bio Inc (PRVB). Other recent insider transactions involving Provention Bio Inc (PRVB) include a net sale of 299,617 shares made by Francisco Leon , a net sale of 5,190,549 shares made by Sessa Capital (master), L.p. , and a net sale of 100,000 shares made by Ashleigh Palmer .
In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc (PRVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,594,666 shares of Provention Bio Inc (PRVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,594,666 shares.
Provention Bio Inc (PRVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Provention Bio Inc Insider Transactions
Nancy Wysenski Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy Wysenski. You might contact Nancy Wysenski via mailing address: 2200 Sunburst Street, Chatsworth Ca 90401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
